Nexgel Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 19

Employees

  • Stock Symbol
  • NXGL

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $3.50
  • (As of Friday Closing)

Nexgel General Information

Description

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.

Contact Information

Website
www.nexgel.com
Formerly Known As
AquaMed Technologies, AquaMed Technologies, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2150 Cabot Boulevard West
  • Suite B
  • Langhorne, PA 19047
  • United States
+1 (215)
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Stock Exchange
NAS
Vertical(s)
LOHAS & Wellness, Manufacturing, Life Sciences
Corporate Office
  • 2150 Cabot Boulevard West
  • Suite B
  • Langhorne, PA 19047
  • United States
+1 (215)

Nexgel Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nexgel Stock Performance

As of 17-Jan-2025, Nexgel’s stock price is $3.50. Its current market cap is $23.8M with 6.79M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.50 $3.61 $1.84 - $5.10 $23.8M 6.79M 128K -$0.59

Nexgel Financials Summary

As of 30-Sep-2024, Nexgel has a trailing 12-month revenue of $6.73M.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 18,603 11,846 1,675 16,821
Revenue 6,729 4,089 2,048 1,551
EBITDA (3,088) (2,730) (3,109) (2,174)
Net Income (3,529) (3,157) (4,746) (4,310)
Total Assets 10,572 9,955 10,357 16,983
Total Debt 3,258 2,798 2,083 4,264
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nexgel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nexgel‘s full profile, request access.

Request a free trial

Nexgel Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Nexgel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021445517-A1 Surgical drape for use on fragile skin and method of use thereof Pending 08-May-2021
EP-4333913-A1 Surgical drape for use on fragile skin and method of use thereof Pending 08-May-2021
ES-2329877-T3 Compositions containing lignin and manufacturing and using procedure of the same. Inactive 20-Sep-2000
DE-60139702-D1 Compositions of lignin and method for their preparation and use Inactive 20-Sep-2000
EP-1328279-B1 Compositions comprising lignin and methods of making and using the same Inactive 20-Sep-2000 A61K31/70
To view Nexgel’s complete patent history, request access »

Nexgel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nexgel Acquisitions (5)

Nexgel’s most recent deal was a Merger/Acquisition with Silly George for . The deal was made on 15-May-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Silly George 15-May-2024 Merger/Acquisition Personal Products
Kenkoderm 01-Dec-2023 Merger/Acquisition Personal Products
CG Converting and Packaging 01-Mar-2023 Merger/Acquisition Other Commercial Services
Sport Defense 01-Jun-2020 Merger/Acquisition Distributors (Healthcare)
Sports Defense 29-May-2020 Merger/Acquisition Commercial/Professional Insurance
To view Nexgel’s complete acquisitions history, request access »

Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Kenkoderm Arlington, VA 2019
Silly George Langhorne, PA

Nexgel FAQs

  • When was Nexgel founded?

    Nexgel was founded in 2009.

  • Where is Nexgel headquartered?

    Nexgel is headquartered in Langhorne, PA.

  • What is the size of Nexgel?

    Nexgel has 19 total employees.

  • What industry is Nexgel in?

    Nexgel’s primary industry is Pharmaceuticals.

  • Is Nexgel a private or public company?

    Nexgel is a Public company.

  • What is Nexgel’s stock symbol?

    The ticker symbol for Nexgel is NXGL.

  • What is the current stock price of Nexgel?

    As of 17-Jan-2025 the stock price of Nexgel is $3.50.

  • What is the current market cap of Nexgel?

    The current market capitalization of Nexgel is $23.8M.

  • What is Nexgel’s current revenue?

    The trailing twelve month revenue for Nexgel is $6.73M.

  • What is Nexgel’s annual earnings per share (EPS)?

    Nexgel’s EPS for 12 months was -$0.59.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »